WIF1 and osteosarcoma: In particular, hypermethylation of the WIF1 promoter, leading to WIF1 silencing (and thus activation of Wnt/beta-catenin signaling), was shown to be associated with various types of cancers including osteosarcoma [24], which indicated the association of WIF1 with osteoporotic diseases.